Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-523
Closed -$306K 254
2023
Q4
$306K Sell
523
-3
-0.6% -$1.68K 0.08% 178
2023
Q3
$273K Buy
526
+12
+2% +$6.24K 0.08% 181
2023
Q2
$278K Buy
514
+29
+6% +$15.9K 0.08% 179
2023
Q1
$261K Buy
485
+43
+10% +$21.9K 0.08% 181
2022
Q4
$226K Buy
+442
New +$215K 0.08% 188
2022
Q3
Sell
-430
Closed -$202K 223
2022
Q2
$202K Sell
430
-46
-10% -$22.4K 0.07% 195
2022
Q1
$241K Buy
476
+9
+2% +$4.32K 0.07% 199
2021
Q4
$247K Buy
+467
New +$224K 0.06% 199

Other funds holding CHE

SkyOak Wealth's CHE Position: Q1 2024 in Review

SkyOak Wealth sold out of Chemed (CHE) in Q1 2024, closing a stake of 523 shares — an estimated $306K sold.

SkyOak Wealth first reported a position in CHE in Q4 2021 and held it in 8 quarters. The position peaked at $306K in Q4 2023. 511 funds tracked by Wall St. Rank hold CHE as of Q1 2024.

  • SkyOak Wealth reported no remaining Chemed position as of Q1 2024 after selling out during the quarter.
  • SkyOak Wealth sold 523 Chemed shares in Q1 2024, an estimated $306K.
  • SkyOak Wealth first reported a position in Chemed in Q4 2021 and held it in 8 quarters.
  • SkyOak Wealth's Chemed position peaked at $306K in Q4 2023.
  • 511 funds tracked by Wall St. Rank held Chemed as of Q1 2024.

Based on SkyOak Wealth's 13F filing for Q1 2024, filed 29 Apr 2024.